Results 1 to 10 of about 14,587 (196)

High prevalence of carbapenem-resistant Enterobacter cloacae complex in a tertiary hospital over a decade [PDF]

Microbiology Spectrum
The aim of this study was to explore the mechanisms and molecular epidemiology of carbapenem resistance in the carbapenem-resistant Enterobacter cloacae complex (CRECC) over a decade in a tertiary hospital in Zhejiang, China.
Shiqi Cai, Jingjing Quan, Zhengan Wang, Huangdu Hu, Xinhong Han, Yan Jiang, Qing Yang, Yunsong Yu, Zhihui Zhou   +8 more
doaj   +7 more sources

Some virulence genes are associated with antibiotic susceptibility in Enterobacter cloacae complex [PDF]

BMC Infectious Diseases
Background Enterobacter cloacae complex (ECC) including different species are isolated from different human clinical samples. ECC is armed by many different virulence genes (VGs) and they were also classified among ESKAPE group by WHO recently.
Fatemeh Mosaffa, Fereshteh Saffari, Mahin Veisi, Omid Tadjrobehkar   +3 more
doaj   +5 more sources

Development of a One-Step Multiplex PCR Assay for Differential Detection of Four species (Enterobacter cloacae, Enterobacter hormaechei, Enterobacter roggenkampii, and Enterobacter kobei) Belonging to Enterobacter cloacae Complex With Clinical Significance [PDF]

Frontiers in Cellular and Infection Microbiology, 2021
Enterobacter cloacae complex (ECC) is composed of multiple species and the taxonomic status is consecutively updated. In last decades ECC is frequently associated with multidrug resistance and become an important nosocomial pathogen. Currently, rapid and
Yang Ji, Peihong Wang, Peihong Wang, Tingting Xu, Yanzi Zhou, Rongchang Chen, Huaiqiu Zhu, Huaiqiu Zhu, Kai Zhou   +8 more
doaj   +5 more sources

IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012–2022 [PDF]

Emerging Infectious Diseases
We characterized a collection of IMI-like–producing Enterobacter spp. isolates (n = 112) in France. The main clone corresponded to IMI-1–producing sequence type 820 E. cloacae subspecies cloacae that was involved in an outbreak.
Cécile Emeraud, Delphine Girlich, Manon Deschamps, Inès Rezzoug, Aymeric Jacquemin, Agnès B. Jousset, Solène Lecolant, Lucy Locher, Aurélien Birer, Thierry Naas, Rémy A. Bonnin, Laurent Dortet   +11 more
doaj   +3 more sources

Surveillance and characterization of carbapenem-resistant Enterobacter cloacae complex from China, 2015–2018 [PDF]

BMC Microbiology
Background The carbapenem-resistant Enterobacter cloacae (CREC) have become a global health concern. However, our understanding of its epidemiological trends and resistance mechanisms still needs to be improved. Methods Ninety-one non-repetitive clinical
Kun Ye, Yongqing Zhang, Xuemei Qiu, Liyan Ye, Jiyong Yang, Yanning Ma   +5 more
doaj   +5 more sources

Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex [PDF]

Microbiology Spectrum
The past decade has witnessed the emergence and spread of carbapenem-resistant Enterobacter cloacae complex (CRECC), presenting a significant clinical challenge and urgently demanding new treatment strategies against antimicrobial resistance (AMR).
Kaixin Yu, Jiming Wu, Mingjing Liao, Jianmin Wang, Chunli Wei, Wenzhang Long, Xuemei Gou, Yang Yang, Jin Wang, Xushan Liang, Chunjiang Li, Xiaoli Zhang   +11 more
doaj   +4 more sources

Species identification, antibiotic resistance, and virulence in Enterobacter cloacae complex clinical isolates from South Korea

Frontiers in Microbiology, 2023
This study aimed to identify the species of Enterobacter cloacae complex (ECC) isolates and compare the genotype, antibiotic resistance, and virulence among them. A total of 183 ECC isolates were collected from patients in eight hospitals in South Korea.
Michidmaral Ganbold, Jungyu Seo, Yu Mi Wi, Ki Tae Kwon, Kwan Soo Ko   +4 more
doaj   +3 more sources

High prevalence of colistin heteroresistance in specific species and lineages of Enterobacter cloacae complex derived from human clinical specimens [PDF]

Annals of Clinical Microbiology and Antimicrobials, 2023
Background Colistin (CST) is a last-line drug for multidrug-resistant Gram-negative bacterial infections. CST-heteroresistant Enterobacter cloacae complex (ECC) has been isolated.
Shota Fukuzawa, Toyotaka Sato, Kotaro Aoki, Soh Yamamoto, Noriko Ogasawara, Chie Nakajima, Yasuhiko Suzuki, Motohiro Horiuchi, Satoshi Takahashi, Shin-ichi Yokota   +9 more
doaj   +2 more sources

Effect of sub-inhibitory tigecycline (½-MIC) on AcrAB-TolC and mar/ram/sox regulatory genes in Enterobacter cloacae complex isolates [PDF]

Frontiers in Cellular and Infection Microbiology
The global rise of antimicrobial resistance (AMR) in Enterobacterales, including the Enterobacter cloacae complex, is narrowing treatment options.
Lukasz Korczak, Piotr Majewski, Pawel Sacha, Dominika Chludzinska, Elzbieta Tryniszewska   +4 more
doaj   +2 more sources

Transcriptomic analysis of tigecycline-induced colistin collateral sensitivity in carbapenem-resistant Enterobacter cloacae complex [PDF]

mSphere
Utilizing treatment strategies based on collateral sensitivity (CS) represents a promising approach to suppressing antibiotic resistance. Although the mechanism of CS between numerous drugs has been researched, the mechanism of CS between tigecycline and
Youtao Liang, Jiming Wu, Jisheng Zhang, Chunli Wei, Jianmin Wang, Wenzhang Long, Xueke Jiang, Yang Yang, Mingjing Liao, Xuemei Gou, Xiaoli Zhang   +10 more
doaj   +2 more sources